Amicus Therapeutics Inc (NASDAQ:FOLD)

During the Trading Day
8.04 +0.21 / +2.68%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
8.04 0.00 / 0.00%
 
Volume: 4.9K
Institutional investors purchased a net $9.2 million shares of FOLD during the quarter ended September 2014 and now own 47.80% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Individual stakeholders48.27%
Other institutional31.72%
Mutual fund holders16.08%

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

11/19/2014PERCEPTIVE ADVISORS LLC  Bought 2.1 Million shares of Amicus Therapeutics Inc
11/28/2014CANDRIAM BELGIUM SA  Bought 400.0 Thousand shares of Amicus Therapeutics Inc
12/31/2014OXFORD ASSET MANAGEMENT LLP  Bought 263.6 Thousand shares of Amicus Therapeutics Inc

Top 10 Owners of Amicus Therapeutics Inc

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Perceptive Advisors LLC15.51%14,439,444120,136,174+2,100,000+17.02%
Redmile Group LLC6.13%5,706,90647,481,458-1,943,362-25.40%
Palo Alto Investors LLC2.10%1,956,37616,277,048-2,015,200-50.74%
Franklin Advisers, Inc.2.01%1,873,10015,584,192+1,873,100--
The Vanguard Group, Inc.1.91%1,773,33114,754,114+412,161+30.28%
D. E. Shaw & Co. LP1.62%1,505,73212,527,690+921,150+157.57%
Millennium Management LLC1.59%1,481,03412,322,203+1,167,075+371.73%
RS Investment Management Co. LLC1.34%1,248,21510,385,149+1,248,215--
Bogle Investment Management LP1.32%1,231,11610,242,885+1,231,116--
UBS AG (Investment Management)1.06%986,0008,203,520-386,700-28.17%

Top 10 Mutual Funds Holding Amicus Therapeutics Inc

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
SPDR S&P Biotech ETF2.23%2,074,14317,256,870+2,074,143--
Vanguard Total Stock Market Index...1.63%1,518,86612,636,96500.00%
iShares Nasdaq Biotechnology ETF1.17%1,084,8109,025,619+1,084,810--
UBS (Lux) Equity Fund - Biotech1.06%986,0008,203,52000.00%
Goldman Sachs Small/Mid Cap Growt...0.93%867,8897,220,836+867,889--
RS Small Cap Growth Fund0.91%843,9347,021,531+843,934--
MFS New Discovery Fund0.75%693,2915,768,181+693,291--
Vanguard Extended Market Index Fu...0.73%680,6145,662,708+99,818+17.19%
Franklin Biotechnology Discovery ...0.70%652,4005,427,96800.00%
Candriam Equities L - Biotechnolo...0.66%610,0005,075,200+400,000+190.48%

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.